ArticleMolecular oncology2020

Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.

Lara Paula Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.